101 related articles for article (PubMed ID: 23294701)
1. A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
Subasinghe NL; Lanter J; Markotan T; Opas E; McKenney S; Crysler C; Hou C; O'Neill J; Johnson D; Sui Z
Bioorg Med Chem Lett; 2013 Feb; 23(4):1063-9. PubMed ID: 23294701
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in CCR2 antagonists.
Xia M; Sui Z
Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
[TBL] [Abstract][Full Text] [Related]
3. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z
Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361
[TBL] [Abstract][Full Text] [Related]
4. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
5. Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.
Zweemer AJ; Nederpelt I; Vrieling H; Hafith S; Doornbos ML; de Vries H; Abt J; Gross R; Stamos D; Saunders J; Smit MJ; Ijzerman AP; Heitman LH
Mol Pharmacol; 2013 Oct; 84(4):551-61. PubMed ID: 23877010
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
7. Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists.
Herath KB; Jayasuriya H; Ondeyka JG; Polishook JD; Bills GF; Dombrowski AW; Cabello A; Vicario PP; Zweerink H; Guan Z; Singh SB
J Antibiot (Tokyo); 2005 Nov; 58(11):686-94. PubMed ID: 16466022
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
Shin N; Baribaud F; Wang K; Yang G; Wynn R; Covington MB; Feldman P; Gallagher KB; Leffet LM; Lo YY; Wang A; Xue CB; Newton RC; Scherle PA
Biochem Biophys Res Commun; 2009 Sep; 387(2):251-5. PubMed ID: 19576173
[TBL] [Abstract][Full Text] [Related]
9. High-content analysis of CCR2 antagonists on human primary monocytes.
Kredel S; Wolff M; Hobbie S; Bieler M; Gierschik P; Heilker R
J Biomol Screen; 2011 Aug; 16(7):683-93. PubMed ID: 21540351
[TBL] [Abstract][Full Text] [Related]
10. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
Zheng Y; Qin L; ZacarÃas NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM
Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736
[TBL] [Abstract][Full Text] [Related]
11. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
Cumming JG; Bower JF; Waterson D; Faull A; Poyser PJ; Turner P; McDermott B; Campbell AD; Hudson J; James M; Winter J; Wood C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3895-9. PubMed ID: 22608963
[TBL] [Abstract][Full Text] [Related]
12. Spiroindenes and spiroindanes as antagonists of CC chemokine receptor 2: WO 2009023754.
Carter PH
Expert Opin Ther Pat; 2010 Feb; 20(2):283-9. PubMed ID: 20100008
[TBL] [Abstract][Full Text] [Related]
13. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.
Kang YS; Cha JJ; Hyun YY; Cha DR
Expert Opin Investig Drugs; 2011 Jun; 20(6):745-56. PubMed ID: 21466412
[TBL] [Abstract][Full Text] [Related]
14. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel small molecule CCR2 antagonists: evaluation of 4-aminopiperidine derivatives.
Vilums M; Zweemer AJ; Dekkers S; Askar Y; de Vries H; Saunders J; Stamos D; Brussee J; Heitman LH; IJzerman AP
Bioorg Med Chem Lett; 2014 Dec; 24(23):5377-80. PubMed ID: 25453791
[TBL] [Abstract][Full Text] [Related]
16. Structural refinement and prediction of potential CCR2 antagonists through validated multi-QSAR modeling studies.
Amin SA; Adhikari N; Baidya SK; Gayen S; Jha T
J Biomol Struct Dyn; 2019 Jan; 37(1):75-94. PubMed ID: 29251559
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
Daly C; Rollins BJ
Microcirculation; 2003 Jun; 10(3-4):247-57. PubMed ID: 12851642
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis.
Min SH; Wang Y; Gonsiorek W; Anilkumar G; Kozlowski J; Lundell D; Fine JS; Grant EP
Biochem Biophys Res Commun; 2010 Jan; 391(1):1080-6. PubMed ID: 20004647
[TBL] [Abstract][Full Text] [Related]
19. Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice.
Eefting D; Bot I; de Vries MR; Schepers A; van Bockel JH; Van Berkel TJ; Biessen EA; Quax PH
J Vasc Surg; 2009 Jul; 50(1):152-60. PubMed ID: 19563963
[TBL] [Abstract][Full Text] [Related]
20. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist.
Wisniewski T; Bayne E; Flanagan J; Shao Q; Wnek R; Matheravidathu S; Fischer P; Forrest MJ; Peterson L; Song X; Yang L; Demartino JA; Struthers M
J Immunol Methods; 2010 Jan; 352(1-2):101-10. PubMed ID: 19913021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
